• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

萨格勒布一家医院中由VIM-1和VIM-4阳性菌引起的疫情。

Outbreak Caused by VIM-1- and VIM-4-Positive in a Hospital in Zagreb.

作者信息

Bedenić Branka, Zarfel Gernot, Luxner Josefa, Grisold Andrea, Nađ Marina, Anušić Maja, Tičić Vladimira, Dobretzberger Verena, Barišić Ivan, Vraneš Jasmina

机构信息

Biomedical Research Institute-BIMIS, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.

Clinical Department for Clinical Microbiology, Infection Control and Prevention, School of Medicine, University Hospital Center Zagreb, University of Zagreb, 10000 Zagreb, Croatia.

出版信息

Pathogens. 2025 Jul 26;14(8):737. doi: 10.3390/pathogens14080737.

DOI:10.3390/pathogens14080737
PMID:40872247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12389321/
Abstract

BACKGROUND/OBJECTIVES: is a frequent causative agent of urinary and wound infections in both community and hospital settings. It develops resistance to expanded-spectrum cephalosporins (ESCs) due to the production of extended-spectrum β-lactamases (ESBLs) or plasmid-mediated AmpC β-lactamases (p-AmpCs). Recently, carbapenem-resistant isolates of emerged due to the production of carbapenemases, mostly belonging to Ambler classes B and D. Here, we report an outbreak of infections due to carbapenem-resistant that were observed in a psychiatric hospital in Zagreb, Croatia. The characteristics of ESBL and carbapenemase-producing isolates, associated with an outbreak, were analyzed.

MATERIALS AND METHODS

The antibiotic susceptibility testing was performed by the disk-diffusion and broth dilution methods. The double-disk synergy test (DDST) and inhibitor-based test with clavulanic and phenylboronic acid were applied to screen for ESBLs and p-AmpCs, respectively. Carbapenemases were screened by the modified Hodge test (MHT), while carbapenem hydrolysis was investigated by the carbapenem inactivation method (CIM) and EDTA-carbapenem-inactivation method (eCIM). The nature of the ESBLs, carbapenemases, and fluoroquinolone-resistance determinants was investigated by PCR. Plasmids were characterized by PCR-based replicon typing (PBRT). Selected isolates were subjected to molecular characterization of the resistome by an Inter-Array Genotyping Kit CarbaResisit and whole-genome sequencing (WGS).

RESULTS

In total, 20 isolates were collected and analyzed. All isolates exhibited resistance to amoxicillin alone and when combined with clavulanic acid, cefuroxime, cefotaxime, ceftriaxone, cefepime, imipenem, ceftazidime-avibactam, ceftolozane-tazobactam, gentamicin, amikacin, and ciprofloxacin. There was uniform susceptibility to ertapenem, meropenem, and cefiderocol. The DDST and combined disk test with clavulanic acid were positive, indicating the production of an ESBL. The MHT was negative in all except one isolate, while the CIM showed moderate sensitivity, but only with imipenem as the indicator disk. Furthermore, eCIM tested positive in all of the CIM-positive isolates, consistent with a metallo-β-lactamase (MBL). PCR and sequencing of the selected amplicons identified VIM-1 and VIM-4. The Inter-Array Genotyping Kit CarbaResist and WGS identified β-lactam resistance genes , , and genes; aminoglycoside resistance genes , , , , , and ; as well as resistance genes for sulphonamides and , trimethoprim , chloramphenicol , and tetracycline .

CONCLUSIONS

This study revealed an epidemic spread of carbapenemase-producing in two wards in a psychiatric hospital. Due to the extensively resistant phenotype (XDR), therapeutic options were limited. This is the first report of carbapenemase-producing in Croatia.

摘要

背景/目的:在社区和医院环境中,[病原体名称未给出]是泌尿系统和伤口感染的常见病原体。由于产生超广谱β-内酰胺酶(ESBLs)或质粒介导的AmpCβ-内酰胺酶(p-AmpCs),它对广谱头孢菌素(ESCs)产生耐药性。最近,由于产生碳青霉烯酶,主要属于安布勒B类和D类,出现了耐碳青霉烯的[病原体名称未给出]分离株。在此,我们报告在克罗地亚萨格勒布的一家精神病医院观察到的耐碳青霉烯[病原体名称未给出]感染暴发。分析了与暴发相关的产ESBL和碳青霉烯酶的[病原体名称未给出]分离株的特征。

材料与方法

采用纸片扩散法和肉汤稀释法进行药敏试验。分别应用双纸片协同试验(DDST)和含克拉维酸及苯硼酸的抑制剂法筛选ESBLs和p-AmpCs。通过改良Hodge试验(MHT)筛选碳青霉烯酶,同时采用碳青霉烯灭活法(CIM)和EDTA-碳青霉烯灭活法(eCIM)研究碳青霉烯水解情况。通过PCR研究ESBLs、碳青霉烯酶和氟喹诺酮耐药决定簇的性质。通过基于PCR的复制子分型(PBRT)对质粒进行鉴定。选择的分离株通过CarbaResisit芯片基因分型试剂盒和全基因组测序(WGS)进行耐药基因组的分子特征分析。

结果

共收集并分析了20株分离株。所有分离株单独对阿莫西林以及与克拉维酸、头孢呋辛、头孢噻肟、头孢曲松、头孢吡肟、亚胺培南、头孢他啶-阿维巴坦、头孢洛扎坦-他唑巴坦、庆大霉素、阿米卡星和环丙沙星联合使用时均表现出耐药性。对厄他培南、美罗培南和头孢地尔均具有一致的敏感性。DDST和含克拉维酸的联合纸片试验呈阳性,表明产生了ESBL。除一株分离株外,所有MHT均为阴性,而CIM显示中等敏感性,但仅以亚胺培南为指示纸片。此外,所有CIM阳性分离株的eCIM检测均为阳性,与金属β-内酰胺酶(MBL)一致。对选定扩增子的PCR和测序鉴定出VIM-1和VIM-4。CarbaResisit芯片基因分型试剂盒和WGS鉴定出β-内酰胺耐药基因[具体基因名称未给出]、[具体基因名称未给出]和[具体基因名称未给出]基因;氨基糖苷类耐药基因[具体基因名称未给出]、[具体基因名称未给出]、[具体基因名称未给出]、[具体基因名称未给出]、[具体基因名称未给出]和[具体基因名称未给出];以及磺胺类耐药基因[具体基因名称未给出]和[具体基因名称未给出]、甲氧苄啶[具体基因名称未给出]、氯霉素[具体基因名称未给出]和四环素[具体基因名称未给出]。

结论

本研究揭示了产碳青霉烯酶的[病原体名称未给出]在一家精神病医院的两个病房中流行传播。由于广泛耐药表型(XDR),治疗选择有限。这是克罗地亚首次关于产碳青霉烯酶的[病原体名称未给出]的报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d195/12389321/3197344fb28c/pathogens-14-00737-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d195/12389321/3197344fb28c/pathogens-14-00737-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d195/12389321/3197344fb28c/pathogens-14-00737-g001.jpg

相似文献

1
Outbreak Caused by VIM-1- and VIM-4-Positive in a Hospital in Zagreb.萨格勒布一家医院中由VIM-1和VIM-4阳性菌引起的疫情。
Pathogens. 2025 Jul 26;14(8):737. doi: 10.3390/pathogens14080737.
2
Whole-Genome Sequencing and Bioinformatics Analysis of ESBL- producing Klebsiella pneumoniae in a Ghanaian teaching hospital.加纳一家教学医院产超广谱β-内酰胺酶肺炎克雷伯菌的全基因组测序及生物信息学分析
BMC Microbiol. 2025 Jul 2;25(1):401. doi: 10.1186/s12866-025-04101-5.
3
First Report of CTX-M-32 and CTX-M-101 in from Zagreb, Croatia.来自克罗地亚萨格勒布的CTX-M-32和CTX-M-101的首次报告。
Antibiotics (Basel). 2025 Apr 30;14(5):462. doi: 10.3390/antibiotics14050462.
4
Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria.阿尔及利亚奇异变形杆菌临床分离株中新出现的多药耐药性的分子驱动因素。
J Glob Antimicrob Resist. 2019 Sep;18:249-256. doi: 10.1016/j.jgar.2019.01.030. Epub 2019 Feb 21.
5
ARGONAUT-III and -V: susceptibility of carbapenem-resistant and multidrug-resistant to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime.ARGONAUT-III 和 -V:碳青霉烯类耐药和多重耐药对双环硼酸β-内酰胺酶抑制剂替加环素与头孢吡肟联合用药的敏感性。
Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0075124. doi: 10.1128/aac.00751-24. Epub 2024 Aug 12.
6
Clonal outbreak caused by VIM-4-producing Proteus mirabilis in a Greek tertiary-care hospital.产 VIM-4 奇异变形杆菌引起的克隆爆发在一家希腊三级保健医院。
Int J Antimicrob Agents. 2020 Aug;56(2):106060. doi: 10.1016/j.ijantimicag.2020.106060. Epub 2020 Jun 20.
7
Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.克罗地亚一家长期护理机构中多重耐药奇异变形杆菌的出现。
Wien Klin Wochenschr. 2016 Jun;128(11-12):404-13. doi: 10.1007/s00508-016-1005-x. Epub 2016 May 25.
8
Clinical outcomes of phenotype-guided treatment in group D carbapenemase-producing bacteremia.产D组碳青霉烯酶菌血症中表型导向治疗的临床结局
Microbiol Spectr. 2025 Jul;13(7):e0027325. doi: 10.1128/spectrum.00273-25. Epub 2025 May 27.
9
Prevalence and antibiotic resistance of extended spectrum β-lactamase producing Escherichia coli in sheep and slaughterhouse environment in Kayseri, Türkiye: A special focus on β-lactamase genes.土耳其开塞利绵羊及屠宰场环境中产超广谱β-内酰胺酶大肠杆菌的流行情况及抗生素耐药性:特别关注β-内酰胺酶基因
Braz J Microbiol. 2025 Jun 11. doi: 10.1007/s42770-025-01708-8.
10
Investigation of carbapenemase-encoding genes in Burkholderia cepacia and Aeromonas sobria isolates from nosocomial infections in Iraqi patients.伊拉克患者医院感染分离出的洋葱伯克霍尔德菌和温和气单胞菌中碳青霉烯酶编码基因的研究。
PLoS One. 2025 Aug 29;20(8):e0315490. doi: 10.1371/journal.pone.0315490. eCollection 2025.

本文引用的文献

1
The Detection of Extensively Drug-Resistant Strains Harboring Both VIM-4 and VIM-75 Metallo-β-Lactamases from Patients in Germany.在德国患者中检测携带VIM-4和VIM-75金属β-内酰胺酶的广泛耐药菌株
Microorganisms. 2025 Jan 25;13(2):266. doi: 10.3390/microorganisms13020266.
2
OXA-48-like carbapenemases in - novel genetic environments and a challenge for detection.OXA-48 类碳青霉烯酶在新型遗传环境中的情况及检测挑战
Emerg Microbes Infect. 2024 Dec;13(1):2353310. doi: 10.1080/22221751.2024.2353310. Epub 2024 May 23.
3
Genetic analysis of resistance and virulence characteristics of clinical multidrug-resistant isolates.
临床多重耐药分离株的耐药性和毒力特征的遗传分析。
Front Cell Infect Microbiol. 2023 Aug 11;13:1229194. doi: 10.3389/fcimb.2023.1229194. eCollection 2023.
4
Prevalence of Antimicrobial Resistance and Clonal Relationship in ESBL/AmpC-Producing Isolated from Meat Products and Community-Acquired Urinary Tract Infection (UTI-CA) in Southern Brazil.巴西南部肉制品及社区获得性尿路感染(UTI-CA)分离出的产ESBL/AmpC菌的耐药性流行情况及克隆关系
Antibiotics (Basel). 2023 Feb 10;12(2):370. doi: 10.3390/antibiotics12020370.
5
Multidrug-Resistant Bacteria in a COVID-19 Hospital in Zagreb.萨格勒布一家新冠肺炎医院中的多重耐药细菌
Pathogens. 2023 Jan 10;12(1):117. doi: 10.3390/pathogens12010117.
6
Prevalence of extended-spectrum β-lactamases, AmpC, and carbapenemases in Proteus mirabilis clinical isolates.奇异变形杆菌临床分离株中广泛β-内酰胺酶、AmpC 和碳青霉烯酶的流行率。
BMC Microbiol. 2022 Oct 11;22(1):247. doi: 10.1186/s12866-022-02662-3.
7
New CTX-M Group Conferring β-Lactam Resistance: A Compendium of Phylogenetic Insights from Biochemical, Molecular, and Structural Biology.赋予β-内酰胺抗性的新型CTX-M组:来自生物化学、分子生物学和结构生物学的系统发育见解汇编
Biology (Basel). 2022 Feb 7;11(2):256. doi: 10.3390/biology11020256.
8
Overview of Changes to the Clinical and Laboratory Standards Institute M100, 31st Edition.临床和实验室标准协会 M100,31 版更改概述。
J Clin Microbiol. 2021 Nov 18;59(12):e0021321. doi: 10.1128/JCM.00213-21. Epub 2021 Sep 22.
9
Evaluation of the RESIST-4 O.K.N.V immunochromatographic lateral flow assay for the rapid detection of OXA-48, KPC, NDM and VIM carbapenemases from cultured isolates.评估RESIST-4 O.K.N.V免疫层析侧向流动分析法用于从培养分离物中快速检测OXA-48、KPC、NDM和VIM碳青霉烯酶。
Access Microbiol. 2019 Jul 1;1(5):e000031. doi: 10.1099/acmi.0.000031. eCollection 2019.
10
Clonal outbreak caused by VIM-4-producing Proteus mirabilis in a Greek tertiary-care hospital.产 VIM-4 奇异变形杆菌引起的克隆爆发在一家希腊三级保健医院。
Int J Antimicrob Agents. 2020 Aug;56(2):106060. doi: 10.1016/j.ijantimicag.2020.106060. Epub 2020 Jun 20.